Advertisement

Browse Subject Areas

?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

Immunomodulatory treatments

Higher levels of IL-1ra, IL-6, IL-8, MCP-1, MIP-3α, MIP-3β, and fractalkine are associated with 90-day mortality in 132 non-immunomodulated hospitalized patients with COVID-19

Liv Rabøl Andersen, Bettina Hindsberger, [ ... ], Thomas Benfield

Anti-inflammatory, antibacterial and immunomodulatory treatment in children with symptoms corresponding to the research condition PANS (Pediatric Acute-onset Neuropsychiatric Syndrome): A systematic review

Mats Johnson, Stephan Ehlers, [ ... ], Susanna M. Wallerstedt

Prevalence and factors leading to unemployment in MS (multiple sclerosis) patients undergoing immunomodulatory treatment in Poland

Dorota Koziarska, Joanna Król, [ ... ], Przemysław Nowacki

Analysis of Lymphocytic DNA Damage in Early Multiple Sclerosis by Automated Gamma-H2AX and 53BP1 Foci Detection: A Case Control Study

Ludwig Rasche, Lisa Heiserich, [ ... ], Klemens Ruprecht

Blood-Brain Barrier Permeability of Normal Appearing White Matter in Relapsing-Remitting Multiple Sclerosis

Henrik Lund, Martin Krakauer, [ ... ], Lars G. Hanson

Glatiramer Acetate Treatment Normalizes Deregulated microRNA Expression in Relapsing Remitting Multiple Sclerosis

Anne Waschbisch, Monika Atiya, [ ... ], Tobias Derfuss

Advertisement

Create a weekly email alert for: Immunomodulatory treatments

You can change these options by clicking profile then "Alerts and Notifications"